Medical Oncology

ISSN 1357-0560

Volume 19, Supplement 1, March 2002

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Guest Editorial
pp. S01-S02(1)
Authors: Michael Keating; Michael Hallek

A Personal History of the CAMPATH-1H Antibody
pp. S03-S10(1)
Author: Herman Waldmann

Current and Developing Chemotherapy for CLL
pp. S11-S20(1)
Author: Emili Montserrat

Clinical Effects of Alemtuzumab (Campath-1H) in B-cell Chronic Lymphocytic Leukemia
pp. S21-S26(1)
Authors: Anders Osterborg; Hakan Mellstedt; Michael Keating

Alemtuzumab in T-Cell Malignancies
pp. S27-S32(1)
Authors: Claire E. Dearden; Estella Matutes; Daniel Catovsky

Alemtuzumab in Stem Cell Transplantation
pp. S33-S48(1)
Author: Geoff Hale

Future Prospects for Alemtuzumab (MabCampath™)
pp. S57-S64(1)
Authors: Kanti Rai; Michael Hallek

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.

Tools

Need to register?
Sign up here

Text size: A | A | A | A